IN-DATE
Y100: Bard Alyte Y-Mesh Graft (Y500)
Photos are for illustration purposes only and may not depict the exact item.
Sign in to add this product to your favorites!
| Price: | $117.00 $11.70 per box of 1 |
|---|---|
| Quantity: | |
| In Stock: | 4 box of 1 |
| Status: | expired |
The item listed above is expired and may be used for educational, training, and non-clinical research purposes only. Any product information appearing below, including the product indication statement, pertains to an in date item only.
AccessGUDID Info
- FDA Product Code: OTO
- FDA Product Code Name: Mesh, surgical, synthetic, urogynecologic, for apical vaginal and uterine prolapse, transabdominally placed
- GMDN Term Code: 60842
- GMDN Term Name: Pelvic organ prolapse surgical mesh, synthetic polymer
- GMDN Term Description: A sterile woven/knitted or porous material comprised of a non-bioabsorbable synthetic polymer (e.g., polypropylene) intended to be permanently implanted into a female patient for reinforcement and/or bridging of the supporting tissues of the pelvic floor for the surgical treatment of vaginal pelvic organ prolapse (POP), including anterior, posterior, or apical prolapse repair. It is typically available with various material attributes (e.g., density, pore size, weave) and may be pre-configured for specific repair or cut to desired size/shape. Disposable devices associated with implantation (e.g., introducer needles) may be included.
Manufacturer
C.R. Bard (a part of BD - Becton, Dickinson and Company) was a global leader in the development and manufacturing of innovative medical technologies. Known for their high-quality products, Bard specialized in solutions for vascular access, urology, oncology, and surgical specialties. Their product portfolio included catheters, biopsy devices, implantable ports, and hernia repair systems, designed to enhance patient care and procedural efficiency. As part of BD, the legacy of C.R. Bard continues to drive advancements in healthcare, delivering trusted solutions that improve outcomes for patients and providers worldwide.
